TaiRx, Inc. (TPEX:6580)
Taiwan · Delayed Price · Currency is TWD 15.55
-2.40 (-13.37%)
Apr 20, 2026, 12:39 PM CST
TaiRx Revenue
In the year 2025, TaiRx had annual revenue of 27.88M TWD with 239.03% growth. TaiRx had revenue of 7.50M in the half year ending June 30, 2025, with 27,692.59% growth.
Revenue
27.88M
Revenue Growth
+239.03%
P/S Ratio
71.28
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.99B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 27.88M | 19.65M | 239.03% |
| Dec 31, 2024 | 8.22M | 3.14M | 61.79% |
| Dec 31, 2023 | 5.08M | -1.84M | -26.59% |
| Dec 31, 2022 | 6.92M | 1.78M | 34.66% |
| Dec 31, 2021 | 5.14M | 1.78M | 53.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Synbio Tech | 1.04B |
| Chunghwa Chemical Synthesis & Biotech | 804.88M |
| Genomics BioSci & Tech. | 708.38M |
| GenMont Biotech Incorporation | 401.23M |
| G&E Herbal Biotechnology | 309.13M |
| Sunny Pharmtech | 290.18M |
| 3D Global Biotech | 206.74M |
| Gwo Xi Stem Cell Applied Technology Co. , | 187.02M |